What are your criteria for starting tolvaptan in adult patients diagnosed with autosomal dominant polycystic kidney disease?  

This question is probably a bit too broad to answer in detail here, but in broad strokes, depending on the age, imaging criteria (Mayo class / total kidney volume), and kidney function of the patient, as well as other clinical factors, you assess the patient's risk of rapid disease progression to ma...